Quantitative assessment of volume-based metabolic parameters in early-stage invasive ductal breast cancer: Impact of different standardized uptake value thresholds on prognostic factors - A comprehensive analysis.
IF 0.9 4区 医学Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Mustafa Erol, Hasan Önner, Meryem I E Karanis, Ahmet E Şen
{"title":"Quantitative assessment of volume-based metabolic parameters in early-stage invasive ductal breast cancer: Impact of different standardized uptake value thresholds on prognostic factors - A comprehensive analysis.","authors":"Mustafa Erol, Hasan Önner, Meryem I E Karanis, Ahmet E Şen","doi":"10.1967/s002449912758","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study compares volume-based metabolic parameters in early-stage invasive ductal breast cancer using different standardized uptake value (SUV) thresholds and examines their association with immunohistochemical factors.</p><p><strong>Subjects and methods: </strong>A retrospective analysis included 135 patients with early-stage invasive ductal breast cancer who underwent preoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT) scans. Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were derived using absolute SUV threshold methods and fixed % maximum tumor SUV threshold methods. Associations with immunohistochemical factors were explored, and receiver operating characteristic curves were generated.</p><p><strong>Results: </strong>Metabolic tumor volume 2.5 and TLG 2.5 showed stronger correlations with maximum tumor SUV values. Metabolic tumor volume 2.0 and TLG 2.0 had superior area under the curve (AUC) values in predicting estrogen and progesterone receptor negativity. Metabolic tumor volume 2.0 and TLG 2.0 were superior in distinguishing low and high-grade tumors.</p><p><strong>Conclusion: </strong>Absolute SUV threshold methods with a threshold of 2.0 are recommended for calculating volume-based metabolic parameters due to their strong correlation with immunohistochemical factors in invasive ductal breast cancer.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"229-235"},"PeriodicalIF":0.9000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hellenic journal of nuclear medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1967/s002449912758","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/9 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study compares volume-based metabolic parameters in early-stage invasive ductal breast cancer using different standardized uptake value (SUV) thresholds and examines their association with immunohistochemical factors.
Subjects and methods: A retrospective analysis included 135 patients with early-stage invasive ductal breast cancer who underwent preoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) scans. Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were derived using absolute SUV threshold methods and fixed % maximum tumor SUV threshold methods. Associations with immunohistochemical factors were explored, and receiver operating characteristic curves were generated.
Results: Metabolic tumor volume 2.5 and TLG 2.5 showed stronger correlations with maximum tumor SUV values. Metabolic tumor volume 2.0 and TLG 2.0 had superior area under the curve (AUC) values in predicting estrogen and progesterone receptor negativity. Metabolic tumor volume 2.0 and TLG 2.0 were superior in distinguishing low and high-grade tumors.
Conclusion: Absolute SUV threshold methods with a threshold of 2.0 are recommended for calculating volume-based metabolic parameters due to their strong correlation with immunohistochemical factors in invasive ductal breast cancer.
期刊介绍:
The Hellenic Journal of Nuclear Medicine published by the Hellenic Society of
Nuclear Medicine in Thessaloniki, aims to contribute to research, to education and
cover the scientific and professional interests of physicians, in the field of nuclear
medicine and in medicine in general. The journal may publish papers of nuclear
medicine and also papers that refer to related subjects as dosimetry, computer science,
targeting of gene expression, radioimmunoassay, radiation protection, biology, cell
trafficking, related historical brief reviews and other related subjects. Original papers
are preferred. The journal may after special agreement publish supplements covering
important subjects, dully reviewed and subscripted separately.